Last reviewed · How we verify
NCT03315312: FISSURE
Occlusal Caries Management in First Permanent Molars in Child Dental Care
Phase 4 trial testing Fluoride Varnishes in Dental Caries Pit and Fissure in 410 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Oral Health Centre of Expertise in Eastern Norway |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 410 |
| Start date | 1 February 2017 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Fluoride Varnishes — full drug profile →
- Fissure Sealants — full drug profile →
Conditions studied
- Dental Caries Pit and Fissure — all drugs for Dental Caries Pit and Fissure →
- Dental Caries in Children — all drugs for Dental Caries in Children →
Sponsor
Oral Health Centre of Expertise in Eastern Norway — full company profile →
Who can join
Adults 6 to 9, any sex, with Dental Caries Pit and Fissure or Dental Caries in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Occlusal caries management in first permanent molars: a pragmatic randomized clinical trial in child dental care Aim of the present study is to evaluate the effectiveness of fissure sealants and fluoride varnish in a pragmatic randomized clinical trial and evaluate whether some specific patient groups benefit more from any particular treatment. The high risk children (having a previous caries experience at 5 years of age) from 2009, 2010 and 2011 birth cohorts (6-, 7- and 8-year-olds) from three counties (Østfold, Oppland and Hedmark) are selected. Children with at least two erupted first permanent molars in the same jaw randomly receive resin-based sealant or a fluoride varnish (Duraphat) during a routine dental examination. Children who already developed caries, had restorations or fissure sealants placed in first molars were excluded from the present study. Fluoride varnish and resin-based fissure sealants are randomly applied on contra-lateral teeth where each child serves as its own control. This study uses a natural clinical setting, where clinicians use methods and procedures that are routinely applied in public dental clinics. The study is approved by the Regional Committee for Medical Research Ethics South East (2016/2002/REK sør-øst C). Sample size calculations: Based on the assumption that 80% of the treated teeth do not get caries and that 10% difference in caries development constitutes a clinically meaningful difference, it is required to recruit 180 participants in the study for the split-mouth design. Considering a potential maximum of annual 20% drop-out rate and a 3-years follow-up, the study will need to recruit 400 participants in order to have at least 206 children at the 3 years of follow-up. Treatments are provided by either dentists or dental hygienists during routine dental examinations. Caregivers of eligible children are informed about the study, the participation is voluntary and an informed written parental consent is obtained in accordance with the directions of the Regional Committee for Medical Research Ethics. In this study, a clinician selects a random treatment for the first tooth by choosing one of the two cards, while a collateral tooth receives an alternative treatment. Subsequently, treatments provided and materials used are recorded on a treatment registration form. During this study, clinicians follow their conventional clinical procedures for applying sealants or fluoride varnish. Information on patient's caries experience and quality of oral hygiene are recorded on treatment registration form. Fluoride varnish is applied three times, at baseline, 6 months and 12 months. Caries on occlusal surfaces of first molars detected at later 24 and 36 months follow-ups will be recorded in the follow-up registration form. The main study outcome is caries occurrence on occlusal tooth surfaces.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents.
Kashbour W, Gupta P, Worthington HV, Boyers D. · · 2020 · cited 56× · PMID 33142363 · DOI 10.1002/14651858.cd003067.pub5 -
Fissure Sealants or Fluoride Varnish? A Randomized Pragmatic Split-Mouth Trial.
Uhlen-Strand MM, Stangvaltaite-Mouhat L, Mdala I, Volden Klepaker I, et al · · 2024 · cited 3× · PMID 38716723 · DOI 10.1177/00220345241248630 -
Failures of Sealed Molars: Three-Year Results from a Multi-Centre, Prospective Study in Public Dental Service in Norway.
Stangvaltaite-Mouhat L, Uhlen-Strand MM, Klepaker IV, Skudutyte-Rysstad R. · · 2025 · cited 1× · PMID 39929156 · DOI 10.1159/000544068
Verify or expand the search:
- PubMed search for NCT03315312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fluoride Varnishes
Trials testing the same drug.
- NCT06426108 — Interventions to Control Hypersensitivity Pain in Teeth With Insisive Molar Hypomineralization · Phase 4 · completed
- NCT04255251 — Effectiveness Silver Diamine Fluoride Versus Sodium Fluoride in Arresting Caries Around Crown Margins in Older Adults · EARLY_PHASE1 · unknown
- NCT03442309 — Comparative Effectiveness of School-based Caries Prevention · NA · completed
- NCT03448107 — Comparative Effectiveness of Treatments to Prevent Dental Caries · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03315312 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oral Health Centre of Expertise in Eastern Norway
- Last refreshed: 31 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03315312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing